Literature DB >> 27225513

Comprehensive review on cardio-oncology: Role of multimodality imaging.

Carol Chen-Scarabelli1, Chad McRee2, Massoud A Leesar1,2, Fadi G Hage1,2, Tiziano M Scarabelli3,4.   

Abstract

Cancer and cardiovascular disease are the two leading causes of mortality worldwide. Evolving oncologic therapy, including the use of newer targeted agents, has led to an improvement in survival from childhood- and adult-onset cancers. Consequently, there has been a growing realization of cardiotoxic complications related to cancer therapy, with some complications manifesting over months to decades after completion of cancer treatment. This paper reviews cancer therapeutics-related cardiovascular toxicity and its manifestations, multimodality imaging techniques for surveillance and detection of this complication, and the current state of knowledge in this emerging field.

Entities:  

Keywords:  Cancer; cardiotoxicity; chemotherapy; imaging; radiation

Mesh：

Substances：

Year:  2016        PMID： 27225513     DOI： 10.1007/s12350-016-0535-y

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


  109 in total

1.  Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity.

Authors:  Michael S Ewer; Scott M Lippman
Journal:  J Clin Oncol       Date:  2005-05-01       Impact factor: 44.544

2.  Alterations of pre- and postsynaptic noradrenergic signaling in a rat model of adriamycin-induced cardiotoxicity.

Authors:  Miran Kenk; James T Thackeray; Stephanie L Thorn; Karan Dhami; Benjamin J Chow; Kathy J Ascah; Jean N DaSilva; Rob S Beanlands
Journal:  J Nucl Cardiol       Date:  2010-02-25       Impact factor: 5.952

3.  Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study.

Authors:  Gregory T Armstrong; Toana Kawashima; Wendy Leisenring; Kayla Stratton; Marilyn Stovall; Melissa M Hudson; Charles A Sklar; Leslie L Robison; Kevin C Oeffinger
Journal:  J Clin Oncol       Date:  2014-03-17       Impact factor: 44.544

Review 4.  Proteasome inhibition in the treatment of cancer.

Authors:  Paul G Richardson; Constantine Mitsiades; Teru Hideshima; Kenneth C Anderson
Journal:  Cell Cycle       Date:  2005-02-03       Impact factor: 4.534

5.  Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.

Authors:  Imran S Syed; James F Glockner; Dali Feng; Philip A Araoz; Matthew W Martinez; William D Edwards; Morie A Gertz; Angela Dispenzieri; Jae K Oh; Diego Bellavia; A Jamil Tajik; Martha Grogan
Journal:  JACC Cardiovasc Imaging       Date:  2010-02

6.  Increasing minority patient participation in cancer clinical trials using oncology nurse navigation.

Authors:  Dennis Ricky Holmes; Jacquelyn Major; Doris Efosi Lyonga; Rebecca Simone Alleyne; Sheilah Marie Clayton
Journal:  Am J Surg       Date:  2011-10-13       Impact factor: 2.565

Review 7.  Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management.

Authors:  Walid Hassan; Hani Al-Sergani; Walid Mourad; Rashed Tabbaa
Journal:  Tex Heart Inst J       Date:  2005

8.  'Real-life' experience of preapproval carfilzomib-based therapy in myeloma - analysis of cardiac toxicity and predisposing factors.

Authors:  Sophia Danhof; Martin Schreder; Leo Rasche; Susanne Strifler; Hermann Einsele; Stefan Knop
Journal:  Eur J Haematol       Date:  2015-09-21       Impact factor: 2.997

9.  Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials.

Authors:  Sandra M Swain; Fredrick S Whaley; Michael S Ewer
Journal:  Cancer       Date:  2003-06-01       Impact factor: 6.860

10.  An International Survey of Health Care Providers Involved in the Management of Cancer Patients Exposed to Cardiotoxic Therapy.

Authors:  Jeffrey Sulpher; Shrey Mathur; Daniel Lenihan; Christopher Johnson; Michele Turek; Angeline Law; Ellamae Stadnick; Franco Dattilo; Nadine Graham; Susan F Dent
Journal:  J Oncol       Date:  2015-08-02       Impact factor: 4.375
View more
  5 in total

Review 1.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2017. Part 1 of 2: Positron emission tomography, computed tomography, and magnetic resonance.

Authors:  Wael A AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2017-11-08       Impact factor: 5.952

2.  The ethics of radiation exposure in cancer-treated patients : Editorial for: Frequent MUGA testing in a myeloma patient: a case-based ethics discussion.

Authors:  Carol Chen-Scarabelli; Tiziano M Scarabelli
Journal:  J Nucl Cardiol       Date:  2016-06-16       Impact factor: 5.952

Review 3.  Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2020: positron emission tomography, computed tomography, and magnetic resonance.

Authors:  Wael A AlJaroudi; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2021-06-08       Impact factor: 5.952

Review 4.  Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research-practice gaps, challenges, and insights.

Authors:  Ping-Pin Zheng; Jin Li; Johan M Kros
Journal:  Med Res Rev       Date:  2017-09-01       Impact factor: 12.944

5.  Elevated Cardiac Troponin in Clinical Scenarios Beyond Obstructive Coronary Artery Disease.

Authors:  Michael Sternberg; Evasio Pasini; Carol Chen-Scarabelli; Giovannii Corsetti; Hemang Patel; Daniele Linardi; Francesco Onorati; Giuseppe Faggian; Tiziano Scarabelli; Louis Saravolatz
Journal:  Med Sci Monit       Date:  2019-09-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.